Background: The COVID-19 pandemic caused >1 million infections during January-March 2020. There is an urgent need for reliable antibody detection approaches to support diagnosis, vaccine development, safe release of individuals from quarantine, and population lock-down exit strategies. We set out to evaluate the performance of ELISA and lateral flow immunoassay (LFIA) devices.
Methods: We tested plasma for COVID (severe acute respiratory syndrome c...Expand abstract
- Publication status:
- Peer review status:
- Under review
- Copyright holder:
- Adams et al.
- Copyright date:
- Rights statement:
- Copyright: © 2020 Adams et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- CC Attribution (CC BY)
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
If you are the owner of this record, you can report an update to it here: Report update to this record